Michael R Angelastro

This inventor holds 26 USPTO granted patents, plus 12 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Inhibitors. Top assignees: Merrell Pharmaceuticals, Inc., Merrell Dow Pharmaceuticals, Aventis Pharmaceuticals Inc.. Active years: 1990-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Angelastro. Retrieved from https://idiyas.com/inventor/michael-r-angelastro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 84.6

CIPO Patents = 12 (Patent Applications = 3)

EPO Patents = 1

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 185(Granted Patents)

Location History:

Loveland, OH (US) (1990 - 1992)
Cincinnati, OH (US) (1995 - 1999)
Mason, OH (US) (1997 - 2004)
Bridgewater, NJ (US) (2007 - 2021)

Company Filing History:

9 out of 194

Merrell Pharmaceuticals, Inc.

patents

8 out of 455

Merrell Dow Pharmaceuticals

patents

5 out of 207

Aventis Pharmaceuticals Inc.

patents

4. 2 out of 236

Hoechst Marion Roussel

patents

5. 2 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

where one patent can have more than one assignee

Years Active: 1990-2021

Loading Chart...

Areas of Expertise:

UDP Glycosyltransferase

Elastase Inhibitors

Dopamine Agonists

HM74 Modulators

Organic Methyleneamines

Beta-Amyloid Inhibitors

Calpain Inhibitors

Steroid 5-Alpha-Reductase

Peptidase Inhibitors

Cyclopropyl Squalene Derivatives

Orally-Active Inhibitors

3-Ketosteroids

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098056 - UDP glycosyltransferase inhibitors and methods of use (2021-08-24),

2. 8883410 - Method for determining the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase (2014-11-11),

3. 7919508 - 3-piperidinylisochroman-5-ols as dopamine agonists (2011-04-05),

4. 7556931 - Furosemide modulators of HM74 (2009-07-07),

5. 7264937 - Oxydecahydronaphthalene modulators of HM74 (2007-09-04),

6. 7232811 - Furosemide modulators of HM74 (2007-06-19),

7. 6693072 - Elastase inhibitors (2004-02-17),

8. 6265381 - Orally-active elastase inhibitors (2001-07-24),

9. 6008196 - Perfluoroalkyl ketone inhibitors of elastase and processes for making (1999-12-28),

10. 5990328 - Process for the preparation of 4-amino-.DELTA.4-3-ketosteroids via (1999-11-23),

11. 5977074 - Inhibitors of .beta.-amyloid protein production (1999-11-02),

12. 5965550 - Process for the preparation of 4-amino-.DELTA..sup.4 -3-ketosteroids via (1999-10-12),

13. 5869475 - Certain 3-ketosteroids used to inhibit steroid 5.alpha.-reductase (1999-02-09),

14. 5750744 - Process for the preparation of 4-amino- 4-3-ketosteroids via 4-nitro- (1998-05-12),

15. 5736520 - Peptidase inhibitors (1998-04-07),

Title: The Inventor Michael R Angelastro

Introduction: Michael R Angelastro is a renowned inventor based in Mason, Ohio, known for his groundbreaking contributions to various fields.

Latest Patents: Michael R Angelastro holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Michael R Angelastro has demonstrated a keen interest in pushing the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Michael R Angelastro has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing that has resulted in the creation of revolutionary products and technologies.

Conclusion: Michael R Angelastro's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.